Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
278.44
+3.23 (1.17%)
Feb 27, 2026, 4:00 PM EST - Market closed
Bio-Rad Laboratories Revenue
In the year 2025, Bio-Rad Laboratories had annual revenue of $2.58B with 0.65% growth. Bio-Rad Laboratories had revenue of $693.20M in the quarter ending December 31, 2025, with 3.85% growth.
Revenue (ttm)
$2.58B
Revenue Growth
+0.65%
P/S Ratio
2.91
Revenue / Employee
$346,738
Employees
7,450
Market Cap
7.52B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.58B | 16.70M | 0.65% |
| Dec 31, 2024 | 2.57B | -104.70M | -3.92% |
| Dec 31, 2023 | 2.67B | -131.00M | -4.67% |
| Dec 31, 2022 | 2.80B | -120.35M | -4.12% |
| Dec 31, 2021 | 2.92B | 376.92M | 14.81% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Smith & Nephew | 5.94B |
| Bruker | 3.44B |
| Globus Medical | 2.94B |
| Insulet | 2.71B |
| Bio-Rad Laboratories | 2.58B |
| Masimo | 1.53B |
| Penumbra | 1.40B |
| LivaNova | 1.39B |
BIO News
- 15 days ago - Bio-Rad Laboratories, Inc. (BIO) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Bio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial Results - Business Wire
- 4 weeks ago - Bio-Rad to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 12, 2026 - Business Wire
- 5 weeks ago - Artisan Mid Cap Value Fund Q4 2025 Performance Discussion And Portfolio Activity - Seeking Alpha
- 6 weeks ago - Longleaf Partners Global Fund 2025 Contributors And Detractors - Seeking Alpha
- 7 weeks ago - Bio-Rad's Management to Host Investor Meetings at J.P. Morgan's 44th Annual Healthcare Conference - Business Wire
- 4 months ago - Bio-Rad Laboratories, Inc. (BIO) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Bio-Rad Reports Third-Quarter 2025 Financial Results - Business Wire